Randomized, Double-Blind, Placebo-Controlled Trial of Autologous CD34+Cell Therapy for Refractory Angina: 2-Year Safety Analysis Losordo, D. W., Henry, T. D., Schatz, R. A., Lee, J. S., Costa, M., Bass, T., Schaer, G. L., Mendelsohn, F., Davidson, C., Waksman, R., Soukas, P. A., Simon, D., Chronos, N., Fortuin, F. D., Huang, P. P., Weintraub, N., Yeung, A., Rosenfield, K., Wong, S. C., Taussig, A., Raval, A. N., Sherman, W., Kereiakes, D., Strumpf, R. K., Port, S., Pieper, K., Ewenstein, B., Story, K. O., Barker, K. B., Harrington, R. A. LIPPINCOTT WILLIAMS & WILKINS. 2010

View details for Web of Science ID 000208231601899